CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 67 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 29.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $748,000 | -18.3% | 305,000 | 0.0% | 0.11% | -12.2% |
| Q3 2015 | $915,000 | -83.1% | 305,000 | -76.7% | 0.12% | -80.5% |
| Q2 2015 | $5,411,000 | +16.2% | 1,310,000 | +21.9% | 0.63% | +18.2% |
| Q1 2015 | $4,655,000 | +64.1% | 1,075,000 | +12.6% | 0.53% | +60.4% |
| Q4 2014 | $2,836,000 | -10.6% | 955,000 | 0.0% | 0.33% | -18.6% |
| Q3 2014 | $3,171,000 | +51.0% | 955,000 | +15.1% | 0.41% | +19.2% |
| Q2 2014 | $2,100,000 | – | 830,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |